About Careers Internship MedBlog Contact us

Slowing Down of Plaque Buildup in Alzheimer's With Antidepressants

by Himabindu Venkatakrishnan on May 15, 2014 at 12:02 PM
 Slowing Down of Plaque Buildup in Alzheimer's With Antidepressants

Development of brain plaque implicated in Alzheimer's disease seems to be reduced with a certain antidepressant, reported Scientists on Wednesday, this time by studying young people without dementia.

The antidepressant citalopram lowered by 37 percent the amount of amyloid beta, the main ingredient in brain plaques, in a selection of 23 healthy adults aged 18-50.


The findings were published in the journal Science Translational Medicine.

Citalopram, a common selective serotonin reuptake inhibitor (SSRI) that was approved for the US market in 1998, also stopped the growth of existing brain plaques in mice with a model of Alzheimer's disease and cut new plaque growth 78 percent.

Previous research has found some elderly people who have taken antidepressants also have less amyloid plaque than people who have not taken the mood-enhancing drugs.

Still researchers cautioned that they have not yet found evidence of a cause and effect.

"We are a long way from making a statement regarding the ability of SSRIs to prevent the cognitive decline associated with AD," said lead author Yvette Sheline, professor of psychiatry, radiology and neurology at the University of Pennsylvania.

The patients in this study were followed for a 24 hour period. Future research will focus again on elderly people who take antidepressants, and follow them for a two-week period.

"If we see a drop in levels of amyloid beta in their spinal fluid after two weeks, then we will know that this beneficial reduction in amyloid beta is sustainable," Sheline said.

Alzheimer's disease affects five million people in the United States, where it is the sixth leading cause of death.

The number of people with Alzheimer's is expected to grow in the coming decades as population expands and more people live to old age.

Source: AFP
Font : A-A+



Recommended Readings

Latest Research News

Breakthrough in Mosquitoes for Fighting Dengue Fever
Ae. aegypti mosquitoes are carriers of "arthropod-borne" or "arbo-" viruses, which encompass the dengue virus, yellow fever virus, Zika virus, and chikungunya virus.
Cerebrospinal Fluid Leaks: Link to Traumatic Brain Injury and Dementia?
Cerebrospinal fluid (CSF) leaks are detected in approximately 1-3% of adults who have experienced a traumatic brain injury.
Astrocyte Activation Through Optogenetics: A New Hope in the Fight Against Alzheimer's
The optogenetic activation of hippocampal astrocytes can be viewed as a novel therapeutic avenue for addressing Alzheimer's disease.
Link Between Cholesterol and Inflammation in Alzheimer's Disease Identified
In Alzheimer's disease condition, the control and adjustment of ABCA7 levels in response to inflammation and the decrease in the availability of cholesterol.
Inflammatory Bowel Disease and Atopic Dermatitis Share Common Links
Atopic dermatitis (AD) and inflammatory bowel disease (IBD) can lead to alterations in the microbiome, and disruptions in the skin and gut barrier.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
Greetings! How can I assist you?MediBot

Slowing Down of Plaque Buildup in Alzheimer's With Antidepressants Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests